Earnings summaries and quarterly performance for ALEXANDRIA REAL ESTATE EQUITIES.
Executive leadership at ALEXANDRIA REAL ESTATE EQUITIES.
Peter M. Moglia
Chief Executive Officer and Chief Investment Officer
Andres R. Gavinet
Chief Accounting Officer
Daniel J. Ryan
Co-President and Regional Market Director – San Diego
Gary D. Dean
Executive Vice President – Real Estate Legal Affairs
Hunter L. Kass
Co-President and Regional Market Director – Greater Boston
Jackie B. Clem
General Counsel and Secretary
Joel S. Marcus
Executive Chairman and Founder
John Hart Cole
Executive Vice President – Capital Markets/Strategic Operations and Co-Regional Market Director – Seattle
Joseph Hakman
Co-Chief Operating Officer and Chief Strategic Transactions Officer
Kristina A. Fukuzaki-Carlson
Executive Vice President – Business Operations
Lawrence J. Diamond
Co-Chief Operating Officer and Regional Market Director – Maryland
Madeleine T. Alsbrook
Executive Vice President – Talent Management
Marc E. Binda
Chief Financial Officer and Treasurer
Orraparn C. Lee
Executive Vice President – Accounting
Board of directors at ALEXANDRIA REAL ESTATE EQUITIES.
Research analysts who have asked questions during ALEXANDRIA REAL ESTATE EQUITIES earnings calls.
Dylan Burzinski
Green Street Advisors, LLC
6 questions for ARE
James Kammert
Evercore ISI
6 questions for ARE
Anthony Paolone
JPMorgan Chase & Co.
5 questions for ARE
Michael Carroll
RBC Capital Markets
5 questions for ARE
Richard Anderson
Wedbush Securities
5 questions for ARE
Vikram Malhotra
Mizuho Financial Group, Inc.
5 questions for ARE
Farrell Granath
Bank of America
4 questions for ARE
Omotayo Okusanya
Deutsche Bank AG
4 questions for ARE
Peter Abramowitz
Jefferies
3 questions for ARE
Wesley Golladay
Robert W. Baird & Co.
3 questions for ARE
Jamie Feldman
Wells Fargo & Company
2 questions for ARE
John Kim
BMO Capital Markets
2 questions for ARE
Nicholas Joseph
Citigroup
2 questions for ARE
Nick Joseph
Citigroup Inc.
2 questions for ARE
Georgi Dinkov
Mizuho
1 question for ARE
James Feldman
Wells Fargo
1 question for ARE
Joshua Dennerlein
BofA Securities
1 question for ARE
Michael Griffin
Citigroup Inc.
1 question for ARE
Nick
Virtue Capital
1 question for ARE
Thomas Catherwood
BTIG
1 question for ARE
William Catherwood
BTIG
1 question for ARE
Recent press releases and 8-K filings for ARE.
- The Law Offices of Frank R. Cruz notifies Alexandria shareholders of a class action alleging misleading statements and omissions by the company.
- Class Period: January 27, 2025 – October 27, 2025; Lead Plaintiff Deadline: January 26, 2026.
- The complaint alleges ARE overstated its life-science campus (LIC) value and growth potential while downplaying years-long declines in LIC value and occupancy stability, rendering its positive statements materially misleading.
- Deadline reminder: Investors with losses exceeding $100,000 from purchases of ARE securities between January 27, 2025 and October 27, 2025 must file lead plaintiff applications by January 26, 2026.
- Allegations: The suit claims Alexandria failed to disclose material information, including a $323.9 million real estate impairment charge (with $206 million tied to its LIC property) and lowered full-year FFO guidance during its Q3 FY25 earnings on October 27, 2025.
- Share price drop: On October 28, 2025, ARE shares fell from $77.87 to $62.94, a roughly 19% decline in one day following the earnings disclosure.
- Legal representation: Kahn Swick & Foti, LLC is available for free case evaluations; ClaimsFiler provides investor support and information at no cost.
- The Law Offices of Frank R. Cruz reminds Alexandria Real Estate Equities shareholders of the class action lead plaintiff deadline of January 26, 2026.
- The complaint covers alleged misstatements made between January 27 and October 27, 2025, about the value and growth potential of its life-science campus (LIC) properties.
- Plaintiffs allege the company overstated property values and downplayed declining occupancy and value trends, making prior positive statements materially misleading.
- Alpaca Real Estate acquired a 227,000-square-foot Class A industrial asset in Atlanta as part of its $250 million Southeast industrial strategy
- The acquisition, completed with Outrigger Industrial, marks the firm’s third industrial transaction in its Southeast portfolio
- The property is in Atlanta’s Stone Mountain submarket, which has a ~3% vacancy rate, offering strategic access to key transportation corridors in a high-growth logistics market
- A class action suit covers Jan. 27, 2025–Oct. 27, 2025, with a Jan. 26, 2026 lead plaintiff deadline.
- The complaint alleges ARE overstated LIC property values and growth prospects, omitting years-long declines in value and occupancy stability.
- It claims defendants’ public statements were materially misleading, lacking a reasonable basis at all relevant times.
- 32nd anniversary of founding, marking the creation of life science real estate as a transformative commercial asset class addressing over 90% of diseases lacking effective treatments.
- Megacampus™ ecosystems deliver strong results: 91% occupancy in Greater Boston, San Francisco Bay Area and San Diego (which account for 71% of rental revenue), 18% above the average market rate as of September 30, 2025.
- From January 1, 2023 through September 30, 2025, combined leasing volume in these three markets reached 105% of the aggregate square footage leased by the next five largest life science real estate owners.
- Tenant retention has averaged over 80% across the past five years, underscoring Alexandria’s platform strength and tenant relationships.
- Class Period: January 27, 2025 – October 27, 2025; Lead Plaintiff Deadline: January 26, 2026
- Plaintiffs allege ARE failed to disclose that life-science campus (LIC) property values and potential growth had been declining for years, leading to overstated asset valuations
- The complaint claims ARE downplayed declining occupancy stability and, as a result, its positive statements on business prospects were materially misleading
- Class action filed against Alexandria Real Estate Equities (NYSE: ARE) covering Jan 27, 2025–Oct 27, 2025, with lead plaintiff deadline on Jan 26, 2026.
- Complaint alleges the company misrepresented its life-science campus (LIC) valuations by omitting years-long declines in property value and occupancy stability.
- Shareholders who incurred losses are encouraged to file a lead plaintiff motion by the deadline to participate in the litigation.
- Grabar Law Office is investigating whether Alexandria Real Estate Equities insiders misled investors about fiscal 2025 revenue, FFO growth, and the Long Island City property; shareholders who bought prior to January 27, 2025 may seek corporate reforms and fund recovery at no cost.
- A probe into Inspire Medical Systems alleges false assurances around its Inspire V device launch and a subsequent 32% stock plunge; shareholders since before August 6, 2024 are eligible to pursue remedies.
- Integer Holdings Corp. officers are accused of overstating their EP device growth prospects; shareholders who purchased prior to July 25, 2024 can join the investigation.
- Synopsys, Inc. insiders face claims of inflating financials in its Ansys acquisition materials and understating Design IP underperformance; shareholders before December 4, 2024 or those receiving SNPS shares in exchange for Ansys stock may participate.
- Investors have until January 26, 2026 to file lead plaintiff applications in the securities class action covering purchases of Alexandria Real Estate Equities (NYSE: ARE) stock between January 27, 2025 and October 27, 2025.
- The lawsuit alleges the company failed to disclose that its third-quarter FY2025 results would miss expectations—due to lower occupancy, slower leasing activity and a $323.9 million impairment charge (including $206 million on its LIC property).
- Following the October 27, 2025 disclosure, Alexandria’s share price plunged 19%, falling from $77.87 to $62.94 on October 28, 2025.
Quarterly earnings call transcripts for ALEXANDRIA REAL ESTATE EQUITIES.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more